SCHEMBL6753756

SCHEMBL6753756

CC(C)(C)OC(=O)NC1CCC(Nc2nc(N(Cc3ccccc3)C3CCNCC3)c3ncn(C4C=CCC4)c3n2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CKS1B P61024 1/20 0.34
▸ SKP1 P63208 1/20 0.34
▸ SKP2 Q13309 1/20 0.34
▸ CDK2 P24941 6/20 0.34
▸ CCNA2 P20248 5/20 0.34
▸ CCNE2 O96020 4/20 0.34
▸ CCNE1 P24864 4/20 0.34
▸ CCNA1 P78396 3/20 0.34
▸ JAK1 P23458 3/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CDK4 P11802 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ CCNB3 Q8WWL7 1/20 0.34
▸ BTK Q06187 2/20 0.33
▸ CDK5 Q00535 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6753818 0.90 CDK2 (0.45) KMT2AL3MBTL1CDK2CCNA2CCNE2
SCHEMBL6753817 0.90 CDK2 (0.45) KMT2AL3MBTL1CDK2CCNA2CCNE2
SCHEMBL6751476 0.86 CCNE2 (0.48) CDK2CCNA2CCNE2CCNE1CCNA1
SCHEMBL6751475 0.86 CCNE2 (0.48) CDK2CCNA2CCNE2CCNE1CCNA1
SCHEMBL4372507 0.83 MERTK (0.39) CDK2CCNA2JAK1FLT3BTK
SCHEMBL4372504 0.83 MERTK (0.39) CDK2CCNA2JAK1FLT3BTK
SCHEMBL4374864 0.80 FLT3 (0.43) KMT2AL3MBTL1CKS1BSKP1SKP2
SCHEMBL4374861 0.80 FLT3 (0.43) KMT2AL3MBTL1CKS1BSKP1SKP2
SCHEMBL4372753 0.70 CDK2 (0.49) CDK2CCNA2CCNE2CCNE1JAK1
SCHEMBL4372748 0.70 CDK2 (0.49) CDK2CCNA2CCNE2CCNE1JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377579-A2 ACYL AND SULFONYL DERIVATIVES OF 6,9-DISUBSTITUTED 2-(TRANS-1,4-DIAMINOCYCLOHEXYL)-PURINES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS Aventis Pharmaceuticals Inc. (US) 2004-01-07 — — EP disclosed
WO-2002042303-A2 ACYL AND SULFONYL DERIVATIVES OF 6,9-DISUBSTITUTED 2-(TRANS-1,4-DIAMINOCYCLOHEXYL)-PURINES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS AVENTIS PHARMACEUTICALS INC. (US) 2002-05-30 — — WO disclosed
Send feedback